- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Baylin Technologies Announces Filing of Preliminary Base Shelf Prospectus
Baylin Technologies (TSX:BYL) has announced it has filed and received a receipt for preliminary short from base shelf prospectus with the Securities Commissions with all of the provinces and territories in Canada. As quoted in the press release: Upon a final short form base shelf prospectus (the “Shelf Prospectus“) becoming effective, these filings will, subject …
Baylin Technologies (TSX:BYL) has announced it has filed and received a receipt for preliminary short from base shelf prospectus with the Securities Commissions with all of the provinces and territories in Canada.
As quoted in the press release:
Upon a final short form base shelf prospectus (the “Shelf Prospectus“) becoming effective, these filings will, subject to securities regulatory requirements, allow the Company to make offerings of up to $200,000,000 of common shares, preferred shares, debt securities, warrants, subscription receipts, units, or any combination of such securities (all of the foregoing, collectively, the “Securities“) during the 25-month period that the Shelf Prospectus is effective. The Securities may be offered separately or together, in amounts, at prices and on terms to be determined based on market conditions at the time of sale and set forth in an accompanying shelf prospectus supplement (“Prospectus Supplement“) and, subject to applicable regulations, may include ‘at-the-market’ transactions, private placements, public offerings or strategic investments.
Unless otherwise specified in a Prospectus Supplement, the net proceeds from the sale of Securities for cash will be used for general corporate purposes including working capital, funding ongoing operations and/or capital requirements, reducing the level of indebtedness outstanding from time to time, discretionary capital programs, research and development, and potential future acquisitions. Each Prospectus Supplement will contain specific information, if any, concerning the use of proceeds from that sale of Securities.
Randy Dewey, CEO stated that: “The filing of this Shelf Prospectus provides flexibility for future securities based financings and this will enhance the Company’s access to the capital markets. This allows the Company to take advantage of opportunities as they arise to increase value for all of our stakeholders.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.